Is this Jhunjhunwala-backed pharma stock still a buy after 30% correction?

Rekha Rakesh Jhunjhunwala, through multiple discretionary trusts, owned 25,199,240 equity shares, or 24.09 per cent stake in Concord Biotech as of September 30, 2024.
Read The Rest at :